BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29636089)

  • 1. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.
    Zhou YZ; Zhao LD; Chen H; Zhang Y; Wang DF; Huang LF; Lv QW; Liu B; Li Z; Wei W; Li H; Liao X; Liu H; Liu X; Jin H; Wang J; Fei YY; Wu QJ; Zhang W; Shi Q; Zheng WJ; Zhang FC; Tang FL; Lipsky PE; Zhang X
    Arthritis Res Ther; 2018 Apr; 20(1):70. PubMed ID: 29636089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
    Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X
    Ann Rheum Dis; 2015 Jun; 74(6):1078-86. PubMed ID: 24733191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
    Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
    J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cream, prepared with Tripterygium wilfordii Hook F and other four medicinals, on joint pain and swelling in patients with rheumatoid arthritis: a double-blinded, randomized, placebo controlled clinical trial.
    Jiao J; Tang X; Gong X; Yin H; Jiang Q; Wei C
    J Tradit Chin Med; 2019 Feb; 39(1):89-96. PubMed ID: 32186028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
    Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
    Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open-label, randomized-controlled trial.
    Luo F; Gau SY; Wu YX; Liao HL; Tang F; Zhong Q; Huang Y; Hou L; Liu ZQ; Cai JL; Cao YP; Lu DM; An Y; Lan WY; Liu C; Chen CM; Jia ET; Yao XM; Wei JC; Ma WK
    Int J Rheum Dis; 2024 Jan; 27(1):e15031. PubMed ID: 38287544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
    Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
    Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
    Zhang X; Xia J; Jiang Y; Pisetsky DS; Smolen JS; Mu R; Dai S; Weinblatt ME; Kvien TK; Li J; Dörner T; Zhang Y; Lu L; Yang C; Yang P; Zhang Y; Xu C; Zhao Z; Lipsky PE
    J Autoimmun; 2024 Jan; 142():103148. PubMed ID: 37967495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
    van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S;
    Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial.
    Jiang Q; Tang XP; Chen XC; Xiao H; Liu P; Jiao J
    BMC Complement Altern Med; 2017 Sep; 17(1):444. PubMed ID: 28870177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
    Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
    Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
    Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial.
    Jiang M; Zha Q; Zhang C; Lu C; Yan X; Zhu W; Liu W; Tu S; Hou L; Wang C; Zhang W; Liang Q; Fan B; Yu J; Zhang W; Liu X; Yang J; He X; Li L; Niu X; Liu Y; Guo H; He B; Zhang G; Bian Z; Lu A
    Sci Rep; 2015 Apr; 5():9700. PubMed ID: 26814847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
    Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
    BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.
    Zhang X; Yang H; Zuo X; Wu L; Peng J; Li Z; Li H; Ji W; Zhang L; Li X; Dai L; Lu L; Yang N; Wei W; Shuai Z; Jiang Y; Liu Y; Lipsky PE; Chen H;
    Clin Immunol; 2023 Oct; 255():109749. PubMed ID: 37657525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis.
    Keystone EC; Pope JE; Thorne JC; Poulin-Costello M; Phan-Chronis K; Vieira A; Haraoui B;
    Rheumatology (Oxford); 2016 Feb; 55(2):327-34. PubMed ID: 26361879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A; Lopez-Olivo MA; Maxwell L; Burls A; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD004525. PubMed ID: 23728649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
    Smolen JS; Wollenhaupt J; Gomez-Reino JJ; Grassi W; Gaillez C; Poncet C; Le Bars M; Westhovens R
    Arthritis Res Ther; 2015 Jun; 17(1):157. PubMed ID: 26063454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
    Detert J; Bastian H; Listing J; Weiß A; Wassenberg S; Liebhaber A; Rockwitz K; Alten R; Krüger K; Rau R; Simon C; Gremmelsbacher E; Braun T; Marsmann B; Höhne-Zimmer V; Egerer K; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2013 Jun; 72(6):844-50. PubMed ID: 22739990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.